<html><style> .textDiv { width: 900px; border: 25px solid #58D3F7; padding: 25px; margin: 25px; font-family: 'Arial', Times, serif; font-size: 16px; text-align: justify;} .title { margin: 50px 50px 50px 25px; font-family: 'Arial', Times, serif; font-size: 40px; font-weight: bold; color:  #58D3F7; text-align: left;} </style><head></head><body><div class='title'>extractUncertainty_Unspecified</div><div class='textDiv'>IPO Quiet Period Expiration: Inovalon Holdings - Inovalon (NASDAQ:INOV) | Seeking Alpha 3.9.2015 ends the 25-day quiet period on INOV.3.10 is the first day the firmâ€™s IPO underwriters can publish reports and recommendations.INOV provides cloud-based services to the healthcare industry.The quiet period expiration event often leads to above market returns in the days leading up to the event.The 25-day quiet period on Inovalon Holdings (NASDAQ: INOV ) will come to an end March 9, 2015, allowing the firm's IPO underwriters to publish reports and recommendations of Inovalon, a technology company that provides cloud-based services to the healthcare industry, on March 10.Inovalon Holdings - Buy Recommendation - PT $32.50 Inovalon Holdings is a technology company that provides cloud-based analytics to assist healthcare clients with improving quality and clinical outcomes, financial performance and utilization.Its predecessor companies began in 1998, and INOV changed its name to Inovalon in 2012.<span style='background-color: #A9E2F3'>The company uses extensive proprietary databases, predictive analytics, advanced integration technology and a high level of expertise to streamline the analytical process and make it accessible to healthcare providers at the point of care.</span>Through its proprietary datasets, Inovalon seeks to identify gaps in care, financial performance, data integrity and quality care.<span style='background-color: #A9E2F3'>The system is used by healthcare organizations located in nearly every county in the United States and Puerto Rico.</span>In addition, the database collects information from over 754,000 physicians , 120 million unique patients and 248,000 clinical facilities, while serving physicians, hospitals, ACOs, researchers and health plan providers.Because Inovalon offers its clients a comprehensive package that serves a broad range of functions in the healthcare industry, the company faces competition across several sectors from organizations that provide solutions in similar areas.These competitors include providers of enterprise-scale IT solution providers, such as Oracle, Dell, SAP, IBM and SAS.In addition, the field includes large scale IT consultants such as Deloitte Consulting and Accenture, and large-scale healthcare-specific providers, such as Verisk, Truven, OptumHealth and McKesson.Point solution providers include Silverlink, Matrix, Altegra, Alere, The Advisory Board and DST Health.CEO and Chairman of the Board Keith Dunleavy, M.D., is ultimately responsible for Inovalon's business plan, expansion of key partnerships, and vision and strategy.He holds a Bachelor's degree in Biology modified with Engineering from Dartmouth College, and a doctorate in medicine from Harvard Medical School.President Robert Wychulis holds responsibility for achieving objectives in performance, product and service delivery, client value achievement and support.Prior to Inovalon, Mr. Wychulis held management positions at HealthPlus, WellPoint/Amerigroup and HealthPlan Southeast.He holds a Bachelor of Political Science from City College of New York and a Masters of Health Administration and Planning from the Wagner School of Public Administration at New York University.Inovalon Holdings' IPO was priced at $27, higher than the expected price range of $21 to $24.The stock opened at $31, 15% higher than its initial price.The stock dipped back to its IPO price, but it has risen steadily and currently trades at $30.57 (3.3.2015 close).Conclusion: Buy Early Before Expiration Event INOV's IPO underwriters will seek to capitalize on the stock's recent growth through the release of positive reports, beginning with the conclusion of the quiet period.These underwriters include Citigroup Capital Markets, Goldman Sachs, Morgan Stanley, BofA Merrill Lynch, Piper Jaffray, Robert W. Baird & Co., UBS Investment Bank, Wells Fargo Securities and William Blair & Co.<span style='background-color: #A9E2F3'>Investors who want to buy into Inovalon Holdings may wish to take advantage of the strong buying opportunity presented by the upcoming quiet period expiration and the fact of it being backed by very powerful underwriters.</span>We have recorded above-market returns of ~2% in the week prior to the event.Our findings have built on previous work done by researchers at the University of Florida who also point out the positive correlation between powerful underwriters, such as those backing INOV, and increased gains at the quiet period expiration.<span style='background-color: #A9E2F3'>Source: IPO Quiet Period Expiration: Inovalon Holdings Disclosure: The author has no positions in any stocks mentioned, but may initiate a long position in INOV over the next 72 hours.</span>(More...)The author wrote this article themselves, and it expresses their own opinions.The author is not receiving compensation for it (other than from Seeking Alpha).The author has no business relationship with any company whose stock is mentioned in this article.We only use your contact details to reply to your request for more information.We do not sell the personal contact data you submit to anyone else.Thank you for your interest in Seeking Alpha PRO We look forward to contacting you shortly for a conversation.Our PRO subscription service was created for fund managers, and the cost of the product is prohibitive for most individual investors.PRO Alerts is our flagship product for individual investors who want to be faster and smarter about their stocks.To learn more about it, click here.If you are an investment professional with over $1M AUM and received this message in error, click here and you will be contacted shortly.We look forward to contacting you when we have an individual investor product ready!</div></body></html>